Breaking News
Sort by:
Top Post
Roche’s Tecentriq Plus Avastin Reduced Risk of Cancer Returning in People with Certain Types of Adjuvant Liver Cancer in a Phase III Study
Roche has announced new data from the Phase III IMbrave050 study that show Tecentriq (atezolizumab) […]
eTheRNA Immunotherapies Opens Office in Hong Kong to Support and Build on its Growing Activities in China and Broader Asia-Pacific
eTheRNA immunotherapies NV (‘eTheRNA’ or the ‘Company’), a clinical-stage company developing mRNA-based immunotherapies for the […]
FDA Clears NYU Langone Genome PACT
The U.S. Food and Drug Administration (FDA) has cleared for clinical lab use a gene […]
Lilly and Kumquat Biosciences Announce Collaboration to Discover and Develop Novel Small Molecules that Stimulate Tumor-Specific Immune Responses
Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and […]
AbbVie and Calico Announce Second Extension of Collaboration Focused on Aging and Age-Related Diseases
AbbVie (NYSE: ABBV) and Calico Life Sciences today announced an extension of their leading-edge collaboration […]
GNTbm's Trial on New Epigenetic Drug Generates Hope for Patients with Breast Cancer
Breast cancer is the most common cancer in women worldwide, especially in Taiwan. In 2018, Taiwan recorded 14,127 […]
First Treatment Approved in England for Advanced Bile Duct Cancer
The drug pemigatinib (Pemazyre) will now be an option for people with a rare type of bile […]
Access to Genetic Results Allows for More Personalised Cancer Treatments
Doctors in Wales are now able to access digital genetic test results for urgent cancer […]
AI Startup Lunit Secures Investment from Guardant Health in a Strategic Funding Round
Lunit, a leading AI startup in AI-powered cancer solutions, today announced a strategic investment of […]
PEP-Therapy Extends Series-A Financing, Raising a Total of €5.4 Million to Progress the Clinical Development of its Lead Candidate PEP-010
PEP-Therapy, a biotechnology company developing cell penetrating peptides as targeted therapies for the treatment of […]
‘Skin Snaps’ and Rapid Tests Among £20 Million NHS Push to Speed Cancer Diagnosis
‘Skin snaps’ and rapid tests for same day diagnosis are among a package of measures […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more